Search results
Showing 421 to 435 of 1003 results for public health medicine & health
Norucholic acid for treating primary sclerosing cholangitis [ID6583]
In development Reference number: GID-TA11782 Expected publication date: TBC
Awaiting development Reference number: GID-TA11695 Expected publication date: TBC
Awaiting development Reference number: GID-TA11583 Expected publication date: TBC
Awaiting development Reference number: GID-TA11658 Expected publication date: TBC
Awaiting development Reference number: GID-TA11716 Expected publication date: TBC
Pimicotinib for treating tenosynovial giant cell tumours when systemic treatment is needed [ID6647]
In development Reference number: GID-TA11859 Expected publication date: TBC
In development Reference number: GID-TA11858 Expected publication date: TBC
This guideline sets out an antimicrobial prescribing strategy for adults, young people and children aged 72 hours and over with impetigo. It aims to optimise antibiotic use and reduce antibiotic resistance.
Find out more about the types of organisations that can register to be a stakeholder at NICE.
Find out more about the types of organisations that can register to be a stakeholder at NICE.
Learning disabilities and behaviour that challenges: service design and delivery (NG93)
This guideline covers services for children, young people and adults with a learning disability (or autism and a learning disability) and behaviour that challenges. It aims to promote a lifelong approach to supporting people and their families and carers, focusing on prevention and early intervention and minimising inpatient admissions.
Inebilizumab for treating AQP4-IgG-seropositive neuromyelitis optica spectrum disorders [ID6430]
Awaiting development Reference number: GID-TA11530 Expected publication date: TBC
Awaiting development Reference number: GID-TA11660 Expected publication date: TBC
Icotrokinra for treating moderate to severe plaque psoriasis in people 12 years and over [ID6579]
In development Reference number: GID-TA11780 Expected publication date: TBC
Masitinib with riluzole for treating amyotrophic lateral sclerosis [ID6257]
In development Reference number: GID-TA11071 Expected publication date: TBC